The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Radiation-induced cell cycle arrest compromised by p21 deficiency
Abstract
The protein p21 is a dual inhibitor of cyclin-dependent kinases and proliferating-cell nuclear antigen (PCNA), both of which are required for passage through the cell cycle. The p21 gene is under the transcriptional control of p53 (ref. 5), suggesting that p21 might promote p53-dependent cell cycle arrest or apoptosis. p21 has also been implicated in cell senescence and in cell-cycle withdrawal upon terminal differentiation. Here we investigate the role of p21 in these processes using chimaeric mice composed partly of p21-/- and partly of p21+/+ cells. Immunohistochemical studies of the p21+/+ and p21-/- components of adult small intestine indicated that deletion of p21 has no detectable effect on the migration-associated differentiation of the four principal intestinal epithelial cell lineages or on p53-dependent apoptosis following irradiation. However, p21-/- mouse embryo fibroblasts are impaired in their ability to undergo G1 arrest following DNA damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [147]
In the citing paper
“Surprisingly, developmental senescence is not required for embryogenesis because embryos lacking p21 show minimal or no developmental defects [56].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [56]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Self-citationAltering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 2,037
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Self-citationMansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Self-citationDulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Research works printed but not linked: 3
- Merritt, A. J. et al. Cancer Res. 54, 614–617 (1994).
- Clarke, A. R., Gledhill, S., Hooper, M. L., Bird, C. C. & Wyllie, A. H. Oncogene 9, 1767–1773 (1994).
- Li, Y.-J., Laurent-Puig, P., Salmon, R. J., Thomas, G. & Hamelin, R. Oncogene 10, 599–601 (1994).
Cited by
Sorted by citations
Items 801–900 of 1,000
Guo, L., Li, Z., Wang, H., Ye, C.-Y., & Zhang, D. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.036 · Cited by 27
Brodie, S. G., Xu, X., Li, C., Kuo, A., Leder, P., & Deng, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204222 · Cited by 27
“Control of the cell cycle during the G1 phase by p53 is primarily through p21 (a potent inhibitor of cyclin dependent kinases (CDKs)), as previously demonstrated using p21-de®cient MEF cells that loose this checkpoint (Brugarolas et al., 1995; Deng et al., 1995).”
MethodDistinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production
Daszkiewicz, L., Vázquez-Mateo, C., Rackov, G., Ballesteros-Tato, A., Weber, K., Madrigal-Avilés, A., Di Pilato, M., Fotedar, A., Fotedar, R., Flores, J. M., et al. (2015) · Scientific Reports · doi:10.1038/srep07691 · Cited by 26
“Glomerulonephritis was graded on kidney sections according to the Berden scale (62): (0) no glomerular lesions, (1) minimal thickening of the mesangium, (2) lesions with noticeable increases in mesangial and glomerular cellularity, (3) lesions characterized by the preceding conditions with superimposed inflammatory ex…”
MethodLing, Y., Huang, G., Fan, L., Wei, L., Zhu, J., Liu, Y., Zhu, C., & Zhang, C. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.082875 · Cited by 26
“p21 transactivation is necessary for the p53-mediated G1 arrest induced by DNA damage with radiation, and anticancer agents need p21 induction.(14) 15 Many researchers have found that reduced expression of p21 indicates a poorer prognosis in ESCC.”
BackgroundAn essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress
Quereda, V., Porlan, E., Cañamero, M., Dubus, P. R., & Malumbres, M. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.112 · Cited by 26
An African-Specific Variant of TP5 3 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression
Indeglia, A., Leung, J. C., Miller, S. A., Leu, J. I.-J., Dougherty, J. F., Clarke, N. L., Kirven, N. A., Shao, C., Ke, L., Lovell, S., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1315 · Cited by 30
Integration of the PRB and P53 Cell Cycle Control Pathways
Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 27
“MEFs derived from p21-null animals fail to undergo normal G1 arrest in response to DNA damage [173].”
Cyclin-dependent kinases as targets for cancer therapy
Shah, M. A., & Schwartz, G. K. (2003) · Cancer chemotherapy and biological response modifiers · doi:10.1016/s0921-4410(03)21007-3 · Cited by 26
Redeuilh, G., Attia, A., Mešter, J., & Sabbah, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205753 · Cited by 26
“The regulation of oestrogen-inducible differentiation-related genes by p21 is not an exclusive mechanism as female mice lacking p21 were found to develop normally and did not show defects in reproductive functions or lactation (Brugarolas et al., 1995; Deng et al., 1995).”
BackgroundPlatelet-rich plasma ameliorates senescence-like phenotypes in a cellular photoaging model
Jia, C., Lu, Y., Bi, B., Chen, L., Yang, Q., Yang, P. C., Guo, Y., Zhu, J., Zhu, N., & Liu, T. (2017) · RSC Advances · doi:10.1039/c6ra26725d · Cited by 24
A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response
Ben‐Oz, B. M., Machour, F. E., Nicola, M., Argoetti, A., Polyak, G., Hanna, R., Kleifeld, O., Mandel‐Gutfreund, Y., & Ayoub, N. (2023) · Nature Communications · doi:10.1038/s41467-023-43495-6 · Cited by 27
Cell cycle control in glomerular disease
Griffin, S., Pichler, R. H., Dittrich, M. O., Durvasula, R. V., & Shankland, S. J. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0120-8 · Cited by 25
“cipal mediator of the p53-dependent G1 arrest that occurs following DNA damage [ 5 ], p27 Kip1 appears to be primarily responsible for mediating extracellular anti-proliferative signals [62, 81].”
p19Ink4d Is a Tumor Suppressor and Controls Pituitary Anterior Lobe Cell Proliferation
Bai, F., Chan, H. L., Smith, M. D., Kiyokawa, H., & Pei, X. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01363-13 · Cited by 27
“sponse after inactivation of the p21 gene (8, 9), increase of tumor”
BackgroundMothersill, C. E., Rusin, A., & Seymour, C. B. (2019) · Cancers · doi:10.3390/cancers11091236 · Cited by 25
“One older study found that p21 deficiency abolishes direct-radiation-induced cell cycle arrest [106].”
BackgroundKurita‐Ochiai, T., Hashizume, T., Yonezawa, H., Ochiai, K., & Yamamoto, M. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00066.x · Cited by 26
“One is the broadly acting CIP/KIP family, including p21, p27 and p57 (Brugarolas et al., 1995; Sherr & Roberts, 1995).”
BackgroundLack of p53-Mediated G1 Arrest in Response to an Environmental Carcinogen
Khan, Q. A., Vousden, K. H., & Dipple, A. (1999) · Oncology · doi:10.1159/000012040 · Cited by 25
“that the expression of p21 waf1/cip1 following genotoxic stress can be substantially influenced at the post-transcriptional level and that different types of DNA-damaging agents differ in their capacity to induce p21 waf1/cip1 mRNA and protein. However, at present the reason for the lack of p21 waf1/cip1 expression in…”
BackgroundAbnormalities in Cell Cycle Control in Cancer and Their Clinical Implications
Sgambato, A., Flamini, G., Cittadini, A. R. M., & Weinstein, I. B. (1998) · Tumori Journal · doi:10.1177/030089169808400401 · Cited by 25
G1/S regulatory mechanisms from yeast to man
Reed, S. I. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_2 · Cited by 25
Indeglia, A., & Murphy, M. E. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2344465 · Cited by 27
“Knockout of CDKN1A in mice causes loss of most, but not all, mechanisms of G1 arrest, as well as the loss of the majority of p53-dependent gene repression (Brugarolas et al. 1995; Fischer 2016).”
BackgroundGenetic Abolishment of Hepatocyte Proliferation Activates Hepatic Stem Cells
Endo, Y., Zhang, M., Yamaji, S., & Cang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031846 · Cited by 24
“We therefore generated compound mutant mice by crossing DDB1;Alb-Cre mice and p21 mice [27].”
MethodTelomere Maintenance and the cGAS-STING Pathway in Cancer
Ebata, H., Loo, T. M., & Takahashi, A. (2022) · Cells · doi:10.3390/cells11121958 · Cited by 25
Culture of mouse prostatic epithelial cells from genetically engineered mice
Barclay, W. W., & Cramer, S. D. (2004) · The Prostate · doi:10.1002/pros.20193 · Cited by 24
“Fleet [8] p21 KO A, D, L, V B6; 129S2-Cdkn1a/J The Jackson laboratory [28]”
BackgroundMa, H., Chen, J., Pan, S., Dai, J., Jin, G., Hu, Z., Shen, H., & Shu, Y. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.11.001 · Cited by 24
Radiosensitization of HT‐29 cells and xenografts by the nitric oxide donor DETANONOate
Gao, X., Saha, D., Kapur, P., Anthony, T., Livingston, E. H., & Huerta, S. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21318 · Cited by 25
Potential new biomarkers for squamous carcinoma of the uterine cervix
van Dam, P. A., Rolfo, C. D., Ruiz, R., Pauwels, P., Berckelaer, C. V., Trinh, X.-B., Gandia, J. F., Bogers, J., & Laere, S. V. (2018) · ESMO Open · doi:10.1136/esmoopen-2018-000352 · Cited by 25
“DTL promotes genomic stability as an essential component of the CUL4-DDB1 complex that controls CDT1 levels.(26) It has been shown that changes in the expression of TP53, which play a major role in the pathogenesis of cervical cancer, affects its downstream miRNAs and their most important gene targets MEIS1, AGTR1, DT…”
BackgroundDNA-damage sensitizers: Potential new therapeutical tools to improve chemotherapy
Michod, D., & Widmann, C. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.04.003 · Cited by 24
“The main 53-induced target protein responsible for cell cycle arrest is 21cip1 (also called p21waf1) [15–17].”
BackgroundVitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture
Albert, D. M., Nickells, R. W., Gamm, D. M., Zimbric, M. L., Schlamp, C. L., Lindstrom, M. J., & Audo, I. S. (2002) · Ophthalmic Genetics · doi:10.1076/opge.23.3.137.7883 · Cited by 24
Lim, I. K., Lee, M. S., Ryu, M. S., Park, T. J., Fujiki, H., Eguchi, H., & Paik, W. K. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199809)23:1 · Cited by 75
Role of Cyclins in Epithelial Response to Oxidants
Clément, A., Henrion‐Caude, A., Besnard, V., & Corroyer, S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.supplement_2.2106069 · Cited by 24
Molecular mechanisms of programmed cell death
McKenna, S. L., McGowan, A. J., & Cotter, T. G. (1998) · Advances in biochemical engineering, biotechnology · doi:10.1007/bfb0102304 · Cited by 24
Ubiquitin in signal transduction and cell transformation
Isaksson, A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00011-x · Cited by 24
Yamato, K., Hashimoto, S., Okahashi, N., Ishisaki, A., Nonaka, K., Koseki, T., Kizaki, M., Ikeda, Y., & Nishihara, T. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4876 · Cited by 24
p53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino
Marney, C. B., Anderson, E. S., Adnan, M., Peng, K.-L., Hu, Y., Weinhold, N., & Schmitt, A. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109329 · Cited by 22
Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
Gillham, C., Reynolds, J. V., & Hollywood, D. P. (2007) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-5-97 · Cited by 23
“It is transcriptionally activated by p53 following DNA damage by ionising radiation, which in turn causes cell cycle arrest, and apoptosis [26,27].”
p21 Protects “Super p53” Mice from the Radiation-Induced Gastrointestinal Syndrome
Sullivan, J. M., Jeffords, L. B., Lee, C., Rodrigues, R. C., Ma, Y., & Kirsch, D. G. (2012) · Radiation Research · doi:10.1667/rr2545.1 · Cited by 23
Hoare, M., & Narita, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89512-3_15 · Cited by 23
(1997) · Trends in Genetics · doi:10.1016/0168-9525(97)90029-9 · Cited by 25
Enns, L., Murray, D. L., & Mirzayans, R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690793 · Cited by 23
“This, in turn, leads to increased expression of the p21WAF1 gene, which encodes an inhibitor of cyclin-dependent kinases that are required for G1/S progression (El-Deiry et al, 1993; Brugarolas et al, 1995).”
Backgroundp21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia
Sáiz-Ladera, C., Lara, M. F., Garin, M. I., Ruiz, S., Santos, M., Lorz, C., García‐Escudero, R., Martínez‐Fernández, M., Bravo, A., Fernández-Capetillo, Ó., et al. (2013) · Oncogene · doi:10.1038/onc.2013.417 · Cited by 22
Cellular senescence and organismal ageing in the absence of p21CIP1/WAF1 in ku80−/− mice
Zhao, B., Benson, E. K., Qiao, R., Wang, X., Kim, S., Manfredi, J. J., Lee, S. W., & Aaronson, S. A. (2008) · EMBO Reports · doi:10.1038/embor.2008.220 · Cited by 22
“The absence of p21 in this complete knockout strain (Brugarolas et al, 1995) was confirmed by Western blot and PCR genotyping (Fig 1C; data not shown).”
BackgroundMethodStaalesen, V., Leirvaag, B., Lillehaug, J. R., & Lønning, P. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0796 · Cited by 22
Zhang, W., Qiao, T., & Zha, L. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2010.0939 · Cited by 22
The Role of MAGEA2 in Head and Neck Cancer
Glazer, C. A., Smith, I. M., Bhan, S., Sun, W., Chang, S. S., Pattani, K. M., Westra, W. H., Khan, Z. H., & Califano, J. A. (2011) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archoto.2011.2 · Cited by 22
Collier, A., Spandau, D. F., & Wek, R. C. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-06-0362 · Cited by 26
“The resulting elevated levels of p21 protein function to inhibit the activity of cyclin/ CDK complexes, which ultimately blocks cell progression from the G1 to the S phase (Brugarolas et al., 1995; Deng et al., 1995; Mandal et al., 1998).”
BackgroundThe protease inhibitor, elafin, induces p53‐dependent apoptosis in human melanoma cells
Yu, K. S., Lee, Y., Kim, C. M., Park, E. H., Choi, J., Lim, D., Chung, Y., & Koh, S. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.25125 · Cited by 22
Soluble Guanylyl Cyclase α1 and p53 Cytoplasmic Sequestration and Down-Regulation in Prostate Cancer
Cai, C., Hsieh, C.-L., Gao, S., Kannan, A., Bhansali, M., Govardhan, K., Dutta, R. N., & Shemshedini, L. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0394 · Cited by 24
Zanghi, J. A., Mendoza, T. P., Knop, R. H., & Miller, W. M. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199811)177:2 · Cited by 26
Induction of apoptosis in lung-cancer cells followingbcl-xL anti-sense treatment
Leech, S. H., Olie, R. A., Gautschi, O. P., Sim�es-W�st, A. P., Tschopp, S., H�ner, R., Hall, J., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000515)86:4 · Cited by 98
Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology
Rudoltz, M. S., Kao, G. D., Blank, K. R., Muschel, R. J., & McKenna, W. G. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80024-5 · Cited by 22
Organ-specific, carcinogen-induced increases in cell proliferation in p53-deficient mice.
Sukata, T., Ozaki, K., Uwagawa, S., Seki, T., Wanibuchi, H., Yamamoto, S., Okuno, Y., & Fukushima, S. (2000) · PubMed · Cited by 21
Nitric Oxide Prevents γ-Radiation-Induced Cell Cycle Arrest by Impairing p53 Function in MCF-7 Cells
Chazotte-Aubert, L., Pluquet, O., Hainaut, P. L., & Ohshima, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4423 · Cited by 22
Kim, H. E., Han, S. J., Kasza, T., Han, R., Choi, H.-S., Palmer, K. C., & Kim, H.-R. C. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00358-1 · Cited by 22
Ball, K. L., & Lane, D. P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0854p.x · Cited by 22
Distinct downstream targets manifest p53-dependent pathologies in mice
Pant, V., Xiong, S., Chau, G. P., Tsai, K. Y., Shetty, G., & Lozano, G. (2016) · Oncogene · doi:10.1038/onc.2016.111 · Cited by 21
What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?
Hayman, L., Chaudhry, W. R., Ревин, В. В., Zhelev, N., & Bourdon, J. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1563484 · Cited by 21
“A deficiency of p21 results in the failure of a cell to initiate cell cycle arrest in response to radiation [37],”
BackgroundKoo, B.-S., Kim, Y., Cho, Y. J., & Kim, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.032 · Cited by 21
Zhang, S.-Y., Park, K. W., Oh, S., Cho, H.-J., Cho, H., Park, J., Cho, Y., Koo, B., Chae, I., Choi, D., et al. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.3 · Cited by 21
PTPRV is a Key Mediator of p53-Induced Cell Cycle Exit
Doumont, G., Martoriati, A., & Marine, J. (2005) · Cell Cycle · doi:10.4161/cc.4.12.2207 · Cited by 21
Rosiglitazone ameliorates senescence-like phenotypes in a cellular photoaging model
Chen, L., Bi, B., Zeng, J., Zhou, Y., Yang, P. C., Guo, Y., Zhu, J., Yang, Q., Zhu, N., & Liu, T. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.01.007 · Cited by 23
A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer
Evert, J., Pathak, S., Sun, X., & Zhang, H. (2018) · Journal of Cancer · doi:10.7150/jca.24474 · Cited by 21
“Recent research emphasized on the role of p53 as a transcription factor which regulates the expression of genes related to cell cycle arrest, apoptosis and DNA repair [30-32], as well as a considerable number of miRNAs dysregulation [16].”
BackgroundJaime, M., Pujol, M. J., Serratosa, J., Pantoja, C., Canela-Canela, N., Casanovas, O., Serrano, M., Agell, N., & Bachs, O. (2002) · Hepatology · doi:10.1053/jhep.2002.32678 · Cited by 21
Regulation of P21 during diabetes-associated stress of the endoplasmic reticulum
Mihailidou, C., Chatzistamou, I., Papavassiliou, A. G., & Kiaris, H. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0018 · Cited by 20
“In order to test whether these protective effects of P21 are also produced during glucotoxicity, pancreatic islets were isolated from WT and P21-deficient mice (Brugarolas et al. 1995) and their survival was assessed after culturing them in media containing increased amounts of glucose.”
MethodWang, Y., Shi, W., Wu, C., Wan, L., Zhao, Y., Zhang, C., Gu, W., & Wang, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111663 · Cited by 20
Tran, A. P., Tralie, C. J., Reyes, J. S., Moosmüller, C., Belkhatir, Z., Kevrekidis, I. G., Levine, A. J., Deasy, J. O., & Tannenbaum, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01069-x · Cited by 21
“This is because this geminin reporter only accumulates during the S/G2/M parts of the cell cycle [44, 45] and p21 is degraded in the G1/S transition [33, 43].”
BackgroundAn HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis
Li, Z.-Y., Zhang, Q., Mao, J.-H., Weise, A., Mrasek, K., Fan, X., Zhang, X., Liehr, T., Lu, K. H., Balmain, A., et al. (2010) · Oncogene · doi:10.1038/onc.2010.19 · Cited by 20
“In eukaryotic DNA damage signaling pathways, tumor suppressor p53 and its transcriptional target CDKN1A (p21) have an essential role in monitoring cell-cycle checkpoints (Brugarolas et al., 1995; Deng et al., 1995; Bunz et al., 1998).”
BackgroundTransgenic zebrafish for modeling hepatocellular carcinoma
Nakayama, J., & Gong, Z. (2020) · MedComm · doi:10.1002/mco2.29 · Cited by 19
Smith, C. C., Li, B., Liu, J., Lee, K.-S., & Aurelian, L. (2011) · Cancer Investigation · doi:10.3109/07357907.2011.584588 · Cited by 20
“Of note, our and previous findings for H11/HspB8 mimic those described for canonical tumor suppressor genes[49–54].”
The Role of Trp53 in the Transcriptional Response to Ionizing Radiation in the Developing Brain
Verheyde, J., de Saint‐Georges, L., Leyns, L., & Benotmane, M. A. (2006) · DNA Research · doi:10.1093/dnares/dsi028 · Cited by 20
Ku70 Serine 155 mediates Aurora B inhibition and activation of the DNA damage response
Fell, V. L., Walden, E. A., Hoffer, S. M., Rogers, S. R., Aitken, A. S., Salemi, L. M., & Schild‐Poulter, C. (2016) · Scientific Reports · doi:10.1038/srep37194 · Cited by 20
p21Cip1 Confers resistance to imatinib in human chronic myeloid leukemia cells
Ferrándiz, N., Caraballo, J. M., Albajar, M., Gómez‐Casares, M. T., López-Jorge, C. E., Blanco, R. E., Delgado, M. D., & León, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.11.017 · Cited by 20
“Also, p21 is a relevant mediator of p53cell cycle arrest [5–7].”
BackgroundAttenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital
Gonzales, A. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1173 · Cited by 20
Mitsumori, K., Wakana, S., Yamamoto, S., Kodama, Y., Yasuhara, K., Nomura, T., Hayashi, Y., & Maronpot, R. R. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199711)20:3 · Cited by 48
Conquering the complexity of p53
Attardi, L. D., & DePinho, R. A. (2003) · Nature Genetics · doi:10.1038/ng0104-7 · Cited by 19
Fukuchi, K., Tomoyasu, S., Watanabe, H. A., Tsuruoka, N., & Gomi, K. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00040-2 · Cited by 19
Orr, M. S., Reinhold, W. C., Yu, L., Schreiber‐Agus, N., & O'Connor, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3803 · Cited by 19
Functional investigations of p53 acetylation enabled by heterobifunctional molecules
Chen, L.-Y., Singha Roy, S. J., Jadhav, A. M., Wang, W. W., Chen, P.-H., Bishop, T., Erb, M. A., & Parker, C. G. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00438 · Cited by 18
p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice
Hill, R. J., Bona, N., Smink, J., Webb, H. K., Crisp, A., Garaycoechea, J. I., & Crossan, G. P. (2024) · Nature Communications · doi:10.1038/s41467-024-46844-1 · Cited by 21
S-phase-coupled apoptosis in tumor suppression
Cho, Y., & Liang, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0666-x · Cited by 19
“Consequently, deletion of p21 from colon cancer cells or mouse embryonic fibroblasts allows p53 to induce apoptosis [99–102].”
BackgroundLung specific expression of a human mutant p53 affects cell proliferation in transgenic mice
Duan, W., Gao, L., Jin, D., Otterson, G. A., & Villalona-Calero, M. A. (2007) · Transgenic Research · doi:10.1007/s11248-007-9154-3 · Cited by 18
“DNA damage induced G1 arrest is primarily dependent on the ability of p53 to transactivate the cell cycle inhibitor p21WAF1/CIP1 (Martin-Caballero et al. 2001; Brugarolas et al. 1995).”
BackgroundMutations in Lyar and p53 are synergistically lethal in female mice
Wang, G., Fulkerson, C. M., Malek, R. A., Ghassemifar, S., Snyder, P. W., & Mendrysa, S. M. (2012) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23048 · Cited by 18
Chromatin modification and disease
Johnson, C. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.12.905 · Cited by 18
“(also known as WAF1 and CIP1), which exerts a G1 cell cycle arrest in response to a variety of stimuli.”
BackgroundLysines in the tetramerization domain of p53 selectively modulate G1 arrest
Beckerman, R., Yoh, K. E., Mattia-Sansobrino, M., Zupnick, A., Laptenko, O., Karni-Schmidt, O., Ahn, J., Byeon, I. L., Keezer, S. M., & Prives, C. L. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1170270 · Cited by 19
Cip/Kip Cell-cycle Inhibitors: A Neuro-oncological Perspective
Mainprize, T. G., Taylor, M. D., Rutka, J. T., & Dirks, P. B. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010671908204 · Cited by 18
“Surprisingly, p21 Cip1−/−mice develop normally, have no organ abnormalities and do not display a predisposition to cancer [21,64].”
BackgroundSchwartz, J. L. (2000) · International Journal of Radiation Biology · doi:10.1080/09553000050111505 · Cited by 18
Tamm, K. P., Okan, İ., Kashuba, E., L√∂wbeer, M., Klein, G., & Székely, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-4-987 · Cited by 18
“…arrest are triggered by different mechanisms. p21}waf-1, a downstream target of wtp53 and a dual inhibitor of cyclin-dependent kinases and proliferating cell nuclear antigen, is partly responsible for p53-mediated growth arrest (Brugarolas et al., 1995 ; Chen et al., 1996b ; Deng et al., 1995).”
BackgroundExpression of p53 and p21 in Primary Glioblastomas
Gross, M. W., Kraus, A., Nashwan, K., Mennel, H.-D., Engenhart‐Cabillic, R., & Schlegel, J. (2005) · Strahlentherapie und Onkologie · doi:10.1007/s00066-005-1304-z · Cited by 18
“Since G1 arrest can be induced by the overexpression of p21 and, furthermore, is abrogated in irradiated p21-deficient cells [3, 40], p21 seems to be the key effector of the G1 arrest in response to DNA damage.”
BackgroundRegulation of the Cell Cycle by the Rb Tumor Suppressor Family
Ewen, M. E. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69686-5_7 · Cited by 18
Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality
Luna, R. M. D. O., Amelse, L. L., Chávez‐Reyes, A., Evans, S. C., Brugarolas, J., Jacks, T., & Lozano, G. (1997) · Nature Genetics · doi:10.1038/ng0897-336 · Cited by 18
Self-citationKoide, N., Matsumoto, Y., Kosugi, S., Chou, D., Sakai∞, K., Hatakeyama, K., Niwa, O., & Kominami, R. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199901)24:1 · Cited by 4
Perez, A. C., Santos-de-Frutos, K., de la Rosa, S., Herranz-Montoya, I., Perna, C., & Djouder, N. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212405 · Cited by 17
“T; Brugarolas et al., 1995; Serrano et al., 1996), confirming that cell cycle arrest observed in ISCs from URI ( Δ / Δ )Int mice is not due to senescence.”
Wang, Z., Wang, H., Guo, C., Yu, F., Zhang, Y., Qiao, L., Zhang, H., & Zhang, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04602-w · Cited by 17
Battistini, J. I., Mastrorilli, V., di Robilant, V. N., Saraulli, D., Marinelli, S., & Vecchioli, S. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032911 · Cited by 17
“Male wild-type and p21-null mice [55] of the same genetic background (129Sv/c57BL6; 50:50; https://www.”
BackgroundTumour suppressors and cellular senescence
Chan, A. S. L., Mowla, S. N., Arora, P., & Jat, P. (2014) · IUBMB Life · doi:10.1002/iub.1335 · Cited by 20
“Mouse embryo fibroblasts null for p21 are unable to undergo a radiation-induced growth arrest (61).”
BackgroundMiz1 Is a Critical Repressor of cdkn1a during Skin Tumorigenesis
Hönnemann, J., Sanz‐Moreno, A., Wolf, E., Eilers, M., & Elsässer, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034885 · Cited by 17
“MizDPOZ mice were crossed on a cdkn2b [46] and cdkn1a [47] deficient background, here designated MizDPOZ;cdkn2b and MizDPOZ;cdkn1a mice, respectively.”
BackgroundZhang, J., Wu, Z., Savin, A., Yang, M., Hsu, Y.-H. R., Jantuan, E., Bacani, J. T. C., & Ingham, R. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-34199-9 · Cited by 17
Cell Cycle Effects in Radiation Oncology
Syljuåsen, R. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-52619-5_101-1 · Cited by 17
Expression and prognostic relevance of p21WAF1 in stage III esophageal squamous cell carcinoma
Liu, J., Hu, Y., Hu, W., Xie, X., Bella, A. É., Fu, J., & Rao, D. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01217.x · Cited by 17
Ferrándiz, N., Martı́n-Pérez, J., Blanco, R. E., Dönertas, D., Weber, A., Eilers, M., Dotto, G. P., Delgado, M. D., & León, J. (2009) · DNA repair · doi:10.1016/j.dnarep.2008.12.001 · Cited by 17
Transcription activity is required for p53-dependent tumor suppression
Gaidarenko, O., & Xu, Y. (2009) · Oncogene · doi:10.1038/onc.2009.290 · Cited by 17
“In this context, although p53-dependent cell-cycle G1/S arrest after DNA damage is abolished in p21 / mice, these mice are genetically stable and are not cancer prone (Brugarolas et al., 1995; Deng et al., 1995).”
Thullberg, M., Welcker, M., Bártková, J., Kjerulff, A. A., Lukas, J., Johan, H. V. E., & Bartek, J. (2000) · Hybridoma · doi:10.1089/027245700315806 · Cited by 17
Metadata
- Authors
- Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Washington University in St. Louis (US)
- Venue
- Nature
- Published
- 1995-10
- Volume
- 377
- Issue
- 6549
- Pages
- 552-557
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969385456
- Cited by
- 1,242
- References
- 24
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 13 · 2023: 29 · 2022: 21 · 2021: 29 · 2020: 22 · 2019: 27 · 2018: 28 · 2017: 31 · 2016: 24 · 2015: 26 · 2014: 26 · 2013: 29 · 2012: 41
- FWCI
- 33.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p21, cell cycle arrest, radiation-induced DNA damage, G1 cell cycle arrest, cyclin-dependent kinases, PCNA, p53, apoptosis, chimeric mice, intestinal epithelial differentiation, mouse embryonic fibroblasts, cellular senescence
- MeSH terms
- Animals, Cell Cycle, Cell Differentiation, Cell Division, Cell Line, Cells, Cultured, Chimera, Enzyme Inhibitors, Gamma Rays, Intestine, Small, Mice, Inbred C57BL, Tumor Suppressor Protein p53, Cyclins, Apoptosis, Protein Serine-Threonine Kinases, Gene Targeting, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review